Biomarker

(Image: Getty/masterzphotois)

How to reduce the odds of failure in late phase clinical trials

By Melissa Fassbender

Improving the prognostic value of early phase data is among one of several ways to increase the probability of successes in drug development, a process which has become more expensive as failure rates have risen, says an industry expert.

(Image: Getty/luchschen)

Quanterix expands biomarker tech to oncology research

By Melissa Fassbender

Quanterix is expanding its biomarker technology platform to oncology with the launch of a new test bed for up to 10-plex assays, which will enable drug developers to expedite clinical trials, says CEO.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers